by Alpha | Oct 17, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
7. NEM, OGC:Barclays upgrades Newmont Mining $NEM and OceanaGold Corp $OGC to Overweight,”both offering attractive sets of nt strategic & op. catalysts”
DOWNGRADES
6. DNKN:$DNKN downgraded to Sector Perform at RBC Capital
7. JPM:$JPM downgraded to Market Perform at BMO Capital, downgraded to Neutral at Buckingham
14. WFC:$WFC downgraded to Market Perform at Keefe Bruyettte & Woods – PT cut $48 from $57
EARNINGS
Trending Social Alerts
1. PTCT:$PTCT — FDA denied first appeal of Translarna Refuse-to-File letter.
2. CAT:BREAKING: Caterpillar CEO Doug Oberhelman to retire in 2017; Jim Umpleby becomes $CAT’s next CEO, Doug Calhoun to become non-exec. chairman
3. BAC:A shaky start ahead for Wall as futures pick up where a two-week losing streak left off. $nflx $BAC earns to come.…
5. REGN:$REGN $TEVA Says FDA Has Placed Phase 2B Fasinumab Study in Chronic Low Back Pain on Clinical Hold
13. NFLX:$NFLX report earnings tomorrow after hours-has closed ⬆⬇ 12.06% on average last 12 earnings reports
Trending News Headlines
1. How Apple Scaled Back Its Titanic Plan to Take on Detroit
Apple Inc. has drastically scaled back its automotive ambitions, leading to hundreds of job cuts and a new direction that, for now, no longer includes building its own car, according to people familiar with the project.
2. Supervalu to Sell Save-A-Lot Chain to Onex for $1.37 Billion
Supervalu Inc. agreed to sell its Save-A-Lot grocery business to Canada’s Onex Corp. for $1.37 billion in cash, offloading a discount chain at a time of heavy price competition in the U.S.
3. Bank of America profit rises 6.6 percent as bond trading picks up
Bank of America Corp (BAC.N), the second-largest U.S. bank by assets, reported its first rise in profit in three quarters on Monday, boosted by strong results from bond trading.
4. Customers pile in, analysts fret as U.S. banks offer rich card awards
Morrie Low, a 27-year-old Seattle cocktail server, has found an unlikely new source of pleasure: credit card companies.
5. Brad Loncar on Twitter
“FDA to $PTCT: stop wasting our time.”
6. Whole foods, once a wall street darling, is in need of an activist’s touch
Shares of Whole Foods have plunged about 15% so far this year, lagging the S&P 500’s 3.5% gain.
7. Iran calls OPEC’s decision to limit output ‘baby step in right direction’
Iran’s deputy oil minister said on Monday that the OPEC’s primary agreement in Algeria to limit oil output at 32.5 million barrels per day was a small step but in right direction.
8. Alphabet (GOOGL) (GOOG) PT Raised to $1070 at Credit Suisse
Credit Suisse analyst Stephen Ju previewed Alphabet’s (NASDAQ: GOOGL) (NASDAQ: GOOG) Q3 and raised his price target on price target of $1,070.00 (from $940.00) as they roll…
9. Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs | Xconomy
For close to a decade, Tom Daniel and George Golumbeski comprised perhaps one of the best-known dealmaking duos in biopharma, striking a slew of alliances
10. Celgene crohn’s pill data unspectacular but perhaps good enough
Investors had reduced expectations for Celgene’s CELG experimental pill for Crohn’s disease, which makes the new clinical data released Sunday night look alright, although doubts will persist.
11. CNBC Now on Twitter
“EARNINGS: Bank of America Q3 EPS $0.41 vs. $0.34 Est.; Q3 Revs. $21.635B vs. $20.965B Est. • $BAC”
Technology News
by Alpha | Oct 14, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
1. ABUS:$ABUS upgraded to Neutral from Sell at Chardan. PT $3
4. DPZ:$DPZ upgraded to buy at Bank of America
8. NTDOY:$NTDOY upgraded to Buy at Nomura
11. UA:$UA upgraded to Overweight at Piper Jaffray
14. ZUMZ:$ZUMZ upgraded to Overweight at Piper Jaffray
DOWNGRADES
9. SAM:$SAM downgraded to Sell at Berenberg
EARNINGS
Trending Social Alerts
1. WFC:$WFC Wells Fargo & Co Q3 16 Earnings Results: -EPS: $1.03 -Revenue: $22.3B
2. JPM:JP Morgan Q3 EPS $1.58 vs $1.39 est, Q3 Revenue $25.5B vs $24.0B est $JPM
3. C:$C Citigroup Inc Q3 16 Earnings Results: -Adj EPS: $1.24 -Adj Revenue: $17.8B
4. XXII:$XXII raises $11.4m at $1.34 with warrants at $1.45
5. BMY:$BMY Receives Positive CHMP Opinion for Opdivo for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
7. TGTX:@BioStocks FBR $TGTX Reiterate OP While Lowering PT to $24 from $27 on TGTX Amending GENUINE Phase III Trial &LADEN…
9. BIOC:$BIOC prices 9M offering @ $1.10, with 100% warrant coverage… doubles the amount of outstanding shares
Trending News Headlines
1. European Medicines Agency – News and Events – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016
An agency of the European Union
2. AMD Reaches Deal With Alibaba to Use Chips in Cloud Service
Advanced Micro Devices Inc., struggling to re-establish its data center chip business, said Alibaba Group Holding Ltd. plans to provide cloud-computing services based on its graphics semiconductors.
3. Deutsche Bank’s Top Investor, Qatar, Is Getting Worried About the Lender’s Outlook
Deutsche Bank’s biggest shareholders, investment vehicles controlled by the Qatari royal family, have recently expressed concern about the threat of legal fines against the lender.
4. Deutsche Bank’s Top Investor, Qatar, Is Getting Worried About the Lender’s Outlook
Deutsche Bank’s biggest shareholders, investment vehicles controlled by the Qatari royal family, have recently expressed concern about the threat of legal fines against the lender.
5. Deutsche Bank considers thousands more job cuts: Report
Deutsche Bank’s finance chief told staff last month that job cuts at the bank could be double that planned, a source told Reuters.
6. Citigroup’s Revenue and Profit Fall, But Still Top Expectations
Citigroup said Friday that third-quarter profit and revenue were down, but results were still better than what analysts had predicted.
7. Wells Fargo Profit Slips as Bank Battles to Restore Reputation
Wells Fargo said its third-quarter profit fell as the nation’s third-largest bank continues to battle outrage over a sales-tactics scandal that led to the departure of CEO John Stumpf this week.
8. Citigroup earnings: $1.24 per share, vs. expected EPS of $1.16
Analysts are looking for Citigroup to report earnings of about $1.16 a share on $17.36 billion in revenue.
9. Monster Beverage (MNST) Declares 3-for-1 Stock Split
Monster Beverage Corporation (NASDAQ: MNST) announced that its Board of Directors has approved a 3-for-1 split of its common stock which will be effected in the form of a 200%…
10. Exclusive: Deutsche Bank considers thousands more job cuts – source
Deutsche Bank’s finance chief told staff representatives last month that job cuts at the bank could be double that planned, a step that could remove 10,000 further employees, a person with direct knowledge of the matter told Reuters.
11. LIVE: Wells Fargo reports first earnings since accounts scandal
Wells Fargo expects earnings per share of $1.01.
12. Hershey Foods (HSY) CEO John Bilbrey to Retire Next Year; Reaffirms Outlook
The Hershey Company (NYSE: HSY) today announced that John P. Bilbrey, Chairman, President and Chief Executive Officer, intends to retire from the company July 1, 2017. Bilbrey will continue as…
13. J.P. Morgan’s Results Beat Estimates, Propelled by Investment Bank
J.P. Morgan said a record third quarter for its investment-bank helped propel profit far above expectations. Shares rose 1.5% premarket.
Technology News
Today's Economic Calendar
8:30 Producer Price Index
8:30 Retail Sales
8:30 Fed's Rosengren: "The Elusive Recovery"
10:00 Business Inventories
10:00 Consumer Sentiment
12:30 PM Janet Yellen speech
1:00 PM Baker-Hughes Rig Count
2:00 PM Treasury Budget
If you enjoy the content from SeekingOptions, please like our Facebook page and subscribe to our Youtube Channel
See you in the chat room
by Alpha | Oct 13, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
3. BMY, MRK:$MRK upgraded to Buy from Neutral at BofA/Merrill, PT $70. $BMY
7. HCA:$HCA – *MW HCA Holdings upgraded to overweight from sector weight at KeyBanc Capital
8. MSFT:$MSFT upgraded to Buy at Zacks Research – PT $64
DOWNGRADES
1. BMY:$BMY downgraded to Buy from Conviction Buy at Goldman Sachs
EARNINGS
Trending Social Alerts
1. OCUL:$OCUL and $REGN Collaboration To Develop Sustained Release Formulation Of Aflibercept For The Treatment Of Wet AMD And Other RetinalDiseases
2. DAL:#BREAKING: Delta Air Lines $DAL Q3 Revenue, $10.48B vs. $10.55B expected
3. TGTX:$TGTX Amends the GENUINE Phase 3 Clinical Trial to Accelerate Study Completion by Revising Primary Endpoint to Overall Response Rate
4. AMRS:$AMRS – $20M equity investment @ $1.40. $100M in annual revenues starting in 2017. Deal more than doubles annual revenue
7. OGXI:$OGXI halt
8. BMRN:$BMRN apparently believes by FDA’s own analysis drisa’s dystrophin data stronger than $SRPT. What ar…
Trending News Headlines
1. Bluebird Bio showcases upgraded gene therapy for rare blood diseases
The enhancements to Lentiglobin increase the number of cells containing corrected, functional genes that can be delivered into patients with two rare inherited blood diseases, Bluebird says.
2. Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose
1002-035 Study Meets Primary Endpoint of Incremental LDL-C Lowering Added to Atorvastatin 80 mg Bempedoic Acid Had No Effect on the PK of Atorvastatin and Was Observed to be Safe and Well-Tolerated Conference …
3. Ulta Beauty Hosts Analyst and Investor Conference and Raises Third Quarter and Fiscal Year 2016 Guidance
Ulta Beauty will host its 2016 analyst and investor conference today, Thursday, October 13, 2016 from 10:00 a.m. to 3:00 p.m. in Chicago, Illinois. In conjunction with this event, the Company raised its financial guidance for the third quarter and full year 2016, and provided an update on its long term
4. Event Details | Investor Relations | Bluebird Bio
Manisha Pai
5. Press Release | Investor Relations | Bluebird Bio
– Consistently demonstrated improved vector copy number (VCN) in transfusion-dependent β-thalassemia (TDT) and severe sickle cell disease (SCD) patient cells in vitro with manufacturing Process 2 –
6. bluebird bio Provides Update on LentiGlobin™ Programs and Research and Development Strategy at Gene Therapy Day | Business Wire
bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic disea
7. Amazon Hiring 120,000 For The Holidays (NASDAQ:AMZN)
Amazon.com, Inc. (NASDAQ: AMZN) needs to hire 120,000 new part-time workers across its entire network to ensure a flawless and efficient shopping experience ahead of the holiday…
8. Georgi Kantchev on Twitter
“Oil at $70/b is too hot, and $50/b too cold for U.S. shale, says @CreditSuisse”
9. Amazon to hire 120,000 temporary workers for holiday season
Amazon.com Inc said it would hire more than 120,000 seasonal workers in the United States for the holiday season, 20 percent more than last year, highlighting the growing threat the e-commerce giant poses to traditional retailers.
10. Deutsche Bank alerts managers to hiring freeze: source
Deutsche Bank (DBKGn.DE) has introduced a hiring freeze as it seeks to cut costs amid a deep strategic overhaul, a source familiar with the matter told Reuters on Thursday.
Technology News
by Alpha | Oct 12, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
1. AAPL:$AAPL upgraded to Positive on iPhone 7 strength at OTR Global
3. BABA:$BABA upgraded to Strong Buy at Vetr Inc.
DOWNGRADES
1. AA:$AA downgraded to Neutral at Bank of America, maintians Neutral rating at Goldman Sachs – PT cut $28 from $30
Trending Social Alerts
2. IPCI:$IPCI Intellipharmaceutics, Mallinckrodt $MNK Enter Exclusive Licensing Agreement for XR Drug Candidates
Trending News Headlines
1. AstraZeneca pulls plug on PhII asthma trial at interim analysis, sinking Synairgen’s stock | FierceBiotech
AstraZeneca has halted a Phase IIa trial of the severe asthma drug it licensed from Synairgen. The Big Pharma took action after an interim analysis raised doubts about whether the study could deliver meaningful data against its primary endpoint, throwing the future of the program into question and wiping 40% off Synairgen’s share price.
2. Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML | Business Wire
Celgene and Agios Form Diagnostic Collaborations for IDH Mutated AML
3. Apple (AAPL) PT Raised to $130 Mizuho; Sees In-Line Q4 and Upside to December Qtr
Mizuho Securities analyst Abhey Lamba previewed Apple’s (NASDAQ: AAPL) Q4 results, reiterating a Buy rating and bumping its price target to $130.00 (from $120.00).Lamba sees revenue and EPS…
4. Weyerhaeuser (WY) to Explore Options for Uruguay Business
Weyerhaeuser Company (NYSE: WY) announced the exploration of strategic alternatives for its timberlands and manufacturing…
5. Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Skip to main page content
6. Stanley black & decker just hammered a nail through sears
One bidder for Sears’ Craftsman unit may have just pulled out of the race.
7. OPEC says it raises oil output, despite deal to cut
OPEC reported an increase in its oil production in September to a multi-year high and raised its forecast for 2017 non-OPEC supply growth, pointing to a larger surplus in the market next year despite the group’s deal to cut output.
Technology News
by Alpha | Oct 11, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
5. MNTA:$mnta upgraded to overweight by Barclays.
11. TWTR:$TWTR upgraded to Hold at Evercore ISI Group – PT $17
12. VA:$VA upgraded to Neutral at JP Morgan – PT raise $52.50 from $50
DOWNGRADES
EARNINGS
Trending Social Alerts
3. NBIX:$NBIX INGREZZA priority review PDUFA is 4/11/2017.
5. SUPN:$SUPN halted
Trending News Headlines
1. Alcoa Falls as Last Earnings Before Split Miss on Sales Slowdown
Alcoa Inc. headed for the biggest drop in a month after the 128-year-old aluminum maker’s last earnings before splitting into two companies missed estimates and it cut forecasts for prized parts businesses.
2. CNBC Now on Twitter
“LATEST: Twitter and Salesforce remain in deal talks – sources (via @davidfaber)”
3. Samsung to Permanently Discontinue Galaxy Note 7 Smartphone
Samsung said it would permanently discontinue production and sales of its embattled Galaxy Note 7 smartphone. Potential losses to Samsung could wipe out the mobile division’s operating profits for the fourth quarter, according to one estimate.
4. zach on Twitter
“$HZNP expected net sales on non-GAAP adj basis at low end of prev annc’d full yr net sales range, 272-274M”
5. Alcoa to report fiscal third-quarter earnings before the bell
Analysts expect Alcoa to report earnings of about 35 cents a share on 5.31 billion in revenue, according to Thomson Reuters.
6. Citi’s UK chief says timing of Brexit contingency plans now key dilemma
The UK head of U.S. bank Citi (C.N) said on Tuesday that the main question facing the finance industry now is when to enact contingency planning after Britain voted to leave the European Union.
7. Samsung to Permanently Discontinue Galaxy Note 7 Smartphone
The move halts production and sale of the defective premium phone.
8. Samsung Kills Off the Galaxy Note 7 Smartphone
The unprecedented move by the South Korean electronics giant is an embarrassing reversal for a respected global brand.
9. Some comment on the Twitter buyout rumours
Twitter is wildly addictive. This is well known and there are people who check twitter more obsessively than anyone checked email. Twitter…
10. Early movers: STJ, YHOO, TWTR, CAG, UBS, CBS, CAT & more
Some of the names on the move ahead of the open.
11. Twitter Is Said to Be in Continued Talks With Salesforce
The company tries to forge ahead despite a constantly shifting chess match of deal discussions and considerations.
12. Exclusive: Russia’s Rosneft boss Sechin says no to OPEC oil cap
Igor Sechin, Russia’s most influential oil executive and the head of state-controlled energy giant Rosneft (ROSN.MM), said his company will not cap oil production as part of a possible agreement with OPEC.
13. Shire said to edge closer to Radius deal – sources
Still, well-placed City sources have told little old Betaville that the London-listed company had now lined up financing from several banks, including Royal Bank of Canada and Morgan Stanley, for the potential acquisition after Radius began working with Bank of America Merrill Lynch to pursue “strategic options” (banker parlance for sale).
14. IEA Head Sees $60 Oil Prompting Surge in North American Output
Crude prices of $60 a barrel would probably trigger a strong increase in North American oil production while trimming global demand growth, the head of the International Energy Agency said.
Technology News
by Alpha | Oct 7, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
6. SCYX:$SCYX upgraded to Strong Buy at WBB Securities.
DOWNGRADES
Trending Social Alerts
1. GWPH:Goldman upgrades SMID biotech to attractive. $GWPH initiated buy at GS with $189/target
2. CLVS:$CLVS down 8% –> Rucaparib 0% ORR for platinum-refractory patients, 25% ORR for platinum-resistant patients
3. SCYX:$SCYX upgraded to Strong Buy at WBB Securities.
6. INCY:$INCY – epacadostat + Keytruda in melanoma PFS rate of 74% at 6 mos., 57% at 12 mos. mPFS not yet reached. Median follow up 56 wks. #ESMO17
8. ALNY:MS $ALNY Revusiran Discontinuation Raises Key Questions; Downgrading PT $36.00 Imbalance of mortality leads
9. SAGE:@tgtxdough Renewed interest in CNS disorders has created a rich pipeline of new candidates Names recommend $AVXS $GWPH $SAGE
10. KITE:@tgtxdough Immuno-oncology continues to emerge as a cornerstone of cancer treatment. Names recommend $INCY $KITE
Trending News Headlines
1. Andy Biotech on Twitter
“$CLVS down 8% –> Rucaparib 0% ORR for platinum-refractory patients, 25% ORR for platinum-resistant patients”
2. Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress | Business Wire
Clovis Oncology (NASDAQ:CLVS) announced today the oral presentation of the primary efficacy and safety data from its NDA dataset for rucaparib at
3. Liquid Biopsy on Twitter
“$INCY $MRK #ESMO16 Update – Thoughts on ECHO-202/KEYNOTE-037 Initial melanoma PFS trend look competitive vs. (cont)
4. Payrolls in U.S. Rise 156,000 as Americans Stream Into Workforce
Employers continued to add to payrolls in September as record openings drew more Americans into the workforce and most found jobs, indicating the U.S. labor market is settling into a pace that will support the economy.
5. Data Presented at ESMO 2016 Adds to Understanding of Abraxane® as a Therapy for Patients with Historically Challenging Solid Tumors (NASDAQ:CELG)
Multiple presentations evaluate ABRAXANE alone or in combination with novel agents and novel regimens to treat mPAC, NSCLC, and MBC SUMMIT, N.J.–(BUSINESS WIRE)– …
6. Bridge and Tunnel Investor
Visit our forum at: bridgeandtunnelinvestor.com
7. Ruby Tuesday, Inc. (NYSE:RT) – Ruby Tuesday Q1 Sales Decline, Closes 95 Stores In Quarter
Shares of Ruby Tuesday, Inc. (NYSE: RT) are down following the release of its Q1 earnings after Thursday’s market close. The restaurant operator’s total revenue…
Technology News
$GRPN Wedbush Expects Upside Surprise from Groupon in Q3, Raises Rating to ‘Outperform’, $6.50 PT
$REGN Teva Pharma $TEVA, Regeneron Announce FDA Clinical Hold Placed on Fasinumab Phase 2b – SI